- Fund Type: Open-End Fund
- Objective: Value
- Asset Class: Equity
- Geographic Focus: U.S.
Columbia Equity Value Fund
+ Add to WatchlistCEQIX:US
12.68 USD 0.09 0.70%As of 09:29:30 ET on 05/22/2013.
Snapshot for Columbia Equity Value Fund (CEQIX)
| Year To Date: | +19.16% | 3-Month: | +11.30% | 3-Year: | - | 52-Week Range: | 9.54 - 12.77 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +7.49% | 1-Year: | +32.71% | 5-Year: | - | Beta vs RLV: | 1.05 |
Fund Profile & Information for CEQIX
Columbia Equity Value Fund is an open-end fund incorporated in the USA. The Fund's objective is growth of capital and income. The Fund invests at least 80% of its net assets in equity securities. These securities may provide income, offer the opportunity for long-term capital appreciation, or both. The Fund uses a value-oriented approach to investing in larger companies.
| Inception Date: | 03-04-2004 | Telephone: | 1-800-862-7919 |
|---|---|---|---|
| Managers: | STEVEN R SCHROLL / DEAN A RAMOS | ||
| Web Site: | www.riversource.com | ||
Fundamentals for CEQIX
| NAV | (on 2013-05-22) 12.68 |
|---|---|
| Assets (M) | (on 2013-05-22) 1,252.26 |
| Fund Leveraged | N |
| Minimum Investment | 0.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for CEQIX
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-03-22) 0.05 |
| Dividend Yield (ttm) | 1.56 |
Fees & Expenses for CEQIX
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.65 |
| Redemption Fee | - |
| 12b1 Fee | 0.00 |
| Expense Ratio | 0.75 |
Top Fund Holdings for CEQIX
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Pfizer Inc | 660,101 | 19,050,515 | 3.034% |
| General Electric Co | 784,705 | 18,142,380 | 2.889% |
| JPMorgan Chase & Co | 376,253 | 17,856,967 | 2.844% |
| Goldman Sachs Group Inc/The | 115,339 | 16,972,134 | 2.703% |
| ACE Ltd | 172,197 | 15,320,367 | 2.440% |
| Johnson & Johnson | 182,799 | 14,903,602 | 2.373% |
| Citigroup Inc | 320,130 | 14,162,551 | 2.255% |
| Merck & Co Inc | 302,615 | 13,384,661 | 2.131% |
| Chevron Corp | 107,389 | 12,759,961 | 2.032% |
| Procter & Gamble Co/The | 164,372 | 12,666,506 | 2.017% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page